Clinical trial
A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa
NCT00782340
Study timeline
Study start (unknown)2008-09-01Date precision: month
Registry last updated2014-05-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-diabetic Neuropathyunresolved
Primary Autonomic Failureunresolved
Dopamine Beta Hydroxylase Deficiencyunresolved
Interventions
PlaceboDRUG
DroxidopaDRUG · verified · RxNorm: droxidopa
Sponsors & collaborators
Chelsea Therapeuticslead sponsor
Chiltern International Inc.collaborator
Mapped research locations
HoustonTexas, United States1PhiladelphiaPennsylvania, United States1TorontoOntario, Canada1MontrealQuebec, Canada1BethesdaMaryland, United States1Little RockArkansas, United States1EdmontonAlberta, Canada1LondonOntario, Canada1CalgaryAlberta, Canada1Kansas CityKansas, United States1ScottsdaleArizona, United States1St. PetersburgFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00782340 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.